BASILE, M.; RUMI, F.; CICCHETTI, A. Budget Impact analysis of ponatinib for the management of patients with chronic myeloid leukemia. Global and Regional Health Technology Assessment, [S. l.], v. 8, n. 1, p. 87–95, 2021. DOI: 10.33393/grhta.2021.2238. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/2238. Acesso em: 26 apr. 2024.